0001209191-18-010365.txt : 20180215 0001209191-18-010365.hdr.sgml : 20180215 20180215161239 ACCESSION NUMBER: 0001209191-18-010365 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180213 FILED AS OF DATE: 20180215 DATE AS OF CHANGE: 20180215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BALOUSEK JOHN CENTRAL INDEX KEY: 0001168586 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33268 FILM NUMBER: 18617824 MAIL ADDRESS: STREET 1: 303 PEACHTREE CENTER AVE STREET 2: SUITE 500 CITY: ALTANTA STATE: GA ZIP: 30303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CENTRAL GARDEN & PET CO CENTRAL INDEX KEY: 0000887733 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190] IRS NUMBER: 680275553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0926 BUSINESS ADDRESS: STREET 1: 1340 TREAT BOULEVARD STREET 2: SUITE 600 CITY: WALNUT CREEK STATE: CA ZIP: 94597 BUSINESS PHONE: 9259484000 MAIL ADDRESS: STREET 1: 1340 TREAT BOULEVARD STREET 2: SUITE 600 CITY: WALNUT CREEK STATE: CA ZIP: 94597 FORMER COMPANY: FORMER CONFORMED NAME: CENTRAL GARDEN & PET COMPANY DATE OF NAME CHANGE: 19941019 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-13 0 0000887733 CENTRAL GARDEN & PET CO CENT 0001168586 BALOUSEK JOHN C/O CENTRAL GARDEN & PET COMPANY 1340 TREAT BLVD, SUITE 600 WALNUT CREEK CA 94597 1 0 0 0 Class A Common Stock 2018-02-13 4 A 0 542 0.00 A 6182 D Class A Common Stock 1455 I By Balousek Family L.P. Common Stock 5160 I By Balousek Family L.P. Stock Option (Right to Buy) 36.94 2018-02-13 4 A 0 5415 0.00 A 2021-08-13 Class A Common Stock 5415 5415 D Restricted stock award granted under the Company's Nonemployee Director Equity Incentive Plan, as amended By Balousek Family L.P. Mr. Balousek is the general partner of Balousek Family L.P. Mr. Balousek disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Stock options granted under the Company's Nonemployee Director Equity Incentive Plan, as amended. One-third of the total options granted will become exercisable at each of 6 months, 18 months and 30 months after February 13, 2018, the date of the grant. /s/ John Balousek 2018-02-14